Pharmacists in Micronesia - Medicare Status, Address, Contact
2 Pharmacists found. Showing 1 - 2
 Dr. Xavier Jamal Tato, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1930 W Stadium Blvd, Ann Arbor, FM 48103 Phone: 734-913-4752 Fax: 734-913-9032 |
 Heydimar Quinones Mora Pharmacist Medicare: Not Enrolled in Medicare Practice Location: Carr 172 Caguas A Cidra, Urb. Turabo Gardens, Caguas, FM 00725 Phone: 787-653-0550 Fax: 787-653-0538 |
News Archive
People with metabolic syndrome may be at higher risk for second stroke, death
People with larger waistlines, high blood pressure and other risk factors that make up metabolic syndrome may be at higher risk for having a second stroke and even dying than people who do not have metabolic syndrome, according to a meta-analysis published in the July 28, 2021, online issue of Neurology, the medical journal of the American Academy of Neurology.
Americans' experience with health law depends on where they live
Some states that embraced the law, like Oregon, have had difficulty enrolling residents because of glitch-ridden online marketplaces, while others like New Hampshire have seen unexpectedly strong enrollments despite prevailing critical views.
UNC scientists confirm and clarify key molecular details of nucleotide excision repair
Day in and day out, in our bodies, the DNA in cells is damaged for a variety of reasons, and thus intercellular DNA-repair systems are fundamental to the maintenance of life.
Advanced Life Sciences Holdings' Restanza promising against tularemia
Advanced Life Sciences Holdings, Inc. (OTC Bulletin Board: ADLS), today announced positive top-line results from a pivotal, non-human primate study of its novel, once-a-day, oral antibiotic Restanza(TM) (cethromycin) against an inhaled lethal dose of tularemia. A 14-day course of Restanza achieved a 100% survival rate at the doses tested. All of the ten animals in the study that received 16 mg/kg once-a-day of Restanza (approximate to a human dose of 300 mg) within 24 hours after exposure to a lethal dose of inhaled tularemia survived while only one of the ten animals that received placebo survived.
FDA accepts Topaz's ivermectin NDA for treatment for head lice infestations
Topaz Pharmaceuticals Inc., a privately held specialty pharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) accepted for filing the New Drug Application (NDA) for the use of ivermectin topical cream as a treatment for head lice infestations in children and adults.
› Verified 2 days ago